摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

(-)-Homolaudanosine | 123355-84-0

中文名称
——
中文别名
——
英文名称
(-)-Homolaudanosine
英文别名
(R)-(+)-homolaudanosine;Homolaudanosine;(1R)-1-[2-(3,4-dimethoxyphenyl)ethyl]-6,7-dimethoxy-2-methyl-3,4-dihydro-1H-isoquinoline
(-)-Homolaudanosine化学式
CAS
123355-84-0
化学式
C22H29NO4
mdl
——
分子量
371.477
InChiKey
AECKSTRRHRODOS-GOSISDBHSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    4
  • 重原子数:
    27
  • 可旋转键数:
    7
  • 环数:
    3.0
  • sp3杂化的碳原子比例:
    0.45
  • 拓扑面积:
    40.2
  • 氢给体数:
    0
  • 氢受体数:
    5

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为产物:
    描述:
    3,4-二甲氧基肉桂酸[(1S,2S)-N-(p-toluensulfonyl)-1,2-diphenylethanediamine](p-cymene)ruthenium (I)硼酸三(2,2,2-三氟乙基)酯 、 palladium 10% on activated carbon 、 氢气 、 sodium formate 、 sodium cyanoborohydride 、 zinc(II) chloride 、 三氯氧磷 作用下, 以 甲醇乙醇N,N-二甲基甲酰胺乙腈 为溶剂, 反应 78.17h, 生成 (-)-Homolaudanosine
    参考文献:
    名称:
    仿生总生物碱。
    摘要:
    使用仿生方法,由花椒苷酰胺原生物碱实现了Dysoxylum生物碱的五步全合成。该合成具有直接酰胺化和Bischler-Napieralski反应形成二氢异喹啉环的特征,然后将其进行Noyori不对称转移氢化,以在C-1处建立立体异构中心。我们的合成序列为Dysoxylum生物碱的生物合成起源提供了重要的视角,因为获得了6种天然生物碱和12种合成类似物,具有很高的对映选择性,总收率高达68%。此外,我们描述了Dysoxylum生物碱对斑马鱼胚胎的急性毒性,将它们的毒性与相应的zanthoxylamide原生物碱的毒性进行了比较,并建立了对映选择性-毒性关系。
    DOI:
    10.1021/acs.joc.9b02093
点击查看最新优质反应信息

文献信息

  • Practical Metal-Free C(sp<sup>3</sup>)H Functionalization: Construction of Structurally Diverse α-Substituted<i>N</i>-Benzyl and<i>N</i>-Allyl Carbamates
    作者:Zhiyu Xie、Lei Liu、Wenfang Chen、Hongbo Zheng、Qingqing Xu、Huiqing Yuan、Hongxiang Lou
    DOI:10.1002/anie.201310193
    日期:2014.4.7
    is a practical and universal CH functionalization of readily removable N‐benzyl and Nallyl carbamates, with a wide range of nucleophiles at ambient temperature promoted by Ph3CClO4. The metal‐free reaction has an excellent functional‐group tolerance, and displays a broad scope with respect to both N‐carbamates and nucleophile partners (a variety of organoboranes and CH compounds). The synthetic utility
    描述了一种实用的和普遍Ç 易于除去h的官能ñ -苄基和Ñ -烯丙基氨基甲酸酯,在环境温度下的宽范围的亲核试剂通过pH促进3 CClO 4。无金属反应具有出色的官能团耐受性,并且在N-氨基甲酸酯和亲核试剂(各种有机硼烷和CH化合物)方面都具有广阔的应用范围。展示了目标以及面向多样性的综合中的综合效用。
  • Asymmetric Electrophilic α-Amidoalkylation, VII1): Generation, Crystal Structure, and Trapping Reactions of a Chiral 6,7-Dimethoxy-1,2,3,4-tetrahydroisoquinoline Derived N-Acyliminium Ion
    作者:Klaus Th. Wanner、Ilona Praschak、Ulrich Nagel
    DOI:10.1002/ardp.19903230605
    日期:——
    The camphanic acid amide 4 has efficiently been oxidized with triphenylcarbenium tetrafluoroborate (3) to yield the chiral N‐acyliminium ion 1. Trapping reactions of 1 with the silyl nucleophiles 7a‐c and 10a‐f proceeded with stereoselective bond formation, affording the diastereomers (R)‐8/(S)‐9a‐c and (R)‐11/(S)‐12a‐f, respectively, with diastereoselectivities of up to 93.9/6.1.
    莰酸酰胺 4 已被三苯基碳鎓四氟硼酸盐 (3) 有效氧化,产生手性 N-酰基胺离子 1。1 与甲硅烷基亲核试剂 7a-c 和 10a-f 的捕获反应进行立体选择性键形成,得到非对映异构体( R)-8/(S)-9a-c 和 (R)-11/(S)-12a-f,分别具有高达 93.9/6.1 的非对映选择性。
  • A Novel Straightforward Synthesis of Enantiopure Tetrahydroisoquinoline Alkaloids
    作者:Rafael Pedrosa、Celia Andrés、Jesús M. Iglesias
    DOI:10.1021/jo001397s
    日期:2001.1.1
    formation of chiral 2,3-substituted perhydro-1,3-benzoxazines derived from (-)-8-aminomenthol, (ii) diastereoselective intramolecular ring opening of the N,O-acetal moiety by an arylmetal generated from the substituent at the nitrogen atom in the perhydrobenzoxazine ring, and (iii) removal of the chiral auxiliary appendage. The starting perhydrobenzoxazines are easily prepared from (-)-8-aminomenthol and two
    描述了一种对映纯的1-取代的四氢异喹啉(THIQ)的新颖,直接,高产的立体选择性方法。在THIQ核形成过程中建立立体中心的成功方法是基于(i)形成衍生自(-)-8-氨基薄荷醇的手性2,3-取代的过氢-1,3-苯并恶嗪,(ii)非对映选择性N,O-乙缩醛部分的分子内开环是由在全氢苯并恶嗪环中氮原子上的取代基产生的芳基金属引起的,和(iii)除去手性辅助附属物。起始的全氢苯并恶嗪很容易由(-)-8-氨基薄荷醇和两种不同的醛制备,并且分子内的开口具有立体特异性,从而形成单一的立体异构体。该方法可以制备多种对映体1取代的THIQ,
  • Asymmetric addition of nucleophiles to C-1 position of isoquinolines using ( S )-alanine derivatives as chiral auxiliaries
    作者:Takashi Itoh、Kazuhiro Nagata、Michiko Miyazaki、Keiko Kameoka、Akio Ohsawa
    DOI:10.1016/s0040-4020(01)00881-x
    日期:2001.10
    were allowed to react with a nucleophile (silyl enol ether or allyltributyltin) in the presence of an acyl chloride derived from (S)-alanine to afford the 1,2-addition products in good chemical yields and high stereoselectivity. The bromo groups were readily removed by a reduction process in which the double bond at C3–C4 was also reduced. Thus the reaction system provided a general method to synthesize
    使5,8-二溴异喹啉衍生物与亲核试剂(甲硅烷基烯醇醚或烯丙基三丁基锡)在衍生自(S)-丙氨酸的酰氯存在下反应,以良好的化学收率和高立体选择性提供1,2-加成产物。溴基很容易通过还原过程除去,在还原过程中,C3–C4处的双键也被还原了。因此,反应体系提供了一种合成不对称的1-取代的四氢异喹啉的通用方法。为了确定反应产物的绝对构型,以对映体纯形式合成(-)-高麦芽糖苷。从中间的N-酰化的异喹啉鎓盐的构象可以合理地理解立体选择性。
  • A Novel Synthesis of Chiral Tetrahydroisoquinolines Employing Silyl Enol Ethers in the Presence of Chiral Acyl Chlorides
    作者:Takashi Itoh、Kazuhiro Nagata、Michiko Miyazaki、Akio Ohsawa
    DOI:10.1055/s-1999-3160
    日期:1999.7
查看更多

同类化合物

1-<2-(4-羟基-3-甲氧基)乙基>-7-羟基-6-甲氧基-1,2,3,4-四氢异喹啉 (1R)-1-(4-methoxyphenyl)-2-<(1R)-1,2,3,4-tetrahydro-6,7-dimethoxy-2-methyl-1-isoquinolyl>ethanol (1R)-1-(4-methoxyphenyl)-2-<(1S)-1,2,3,4-tetrahydro-6,7-dimethoxy-2-methyl-1-isoquinolyl>ethanol (1S)-1-(4-methoxyphenyl)-2-<(1S)-1,2,3,4-tetrahydro-6,7-dimethoxy-2-methyl-1-isoquinolyl>ethanol (1S)-1-(4-methoxyphenyl)-2-<(1R)-1,2,3,4-tetrahydro-6,7-dimethoxy-2-methyl-1-isoquinolyl>ethanol Isoautumnaline 6-benzyloxy-1-(3-benzyloxy-4,5-dimethoxyphenethyl)-7-methoxy-2-methyl-1,2,3,4-tetrahydroisoquinoline 7-Benzyloxy-6-methoxy-2-methyl-1-(4-methoxy-phenethyl)-1,2,3,4-tetrahydro-isochinolin 1-(4-methoxyphenethyl)-1,2,3,4-tetrahydro-6-methoxy-2-methyl-7-isoquinolinol (+)-colchiethine 7-hydroxy-6-methoxy-1-(3',4',5'-trimethoxyphenethyl)-N-methyl-1,2,3,4-tetrahydroisoquinoline (+)-colchiethanamine (+/-)-N,N-Dimethyl-6,7,3',4'-tetramethoxyphenylethyl-1,2,3,4-tetrahydroisoquinolinium iodide [(1S)-7-methoxy-1-[2-(4-methoxyphenyl)ethyl]-2-methyl-3,4-dihydro-1H-isoquinolin-6-yl] 2,2-dimethylpropanoate [4-[2-[(1S)-6-(2,2-dimethylpropanoyloxy)-7-methoxy-2-methyl-3,4-dihydro-1H-isoquinolin-1-yl]ethyl]phenyl] 2,2-dimethylpropanoate (1S)-6,7-dimethoxy-2-methyl-1-[2-(3,4,5-trimethoxyphenyl)ethyl]-1,2,3,4-tetrahydroisoquinoline (S)-autumnaline 6,7-dimethoxy-1-(4-methoxyphenylethyl)-2-methyl-1,2,3,4-tetrahydroisoquinoline 1,2,3,4-tetrahydro-6-hydroxy-7-methoxy-1-(2-(3',4'-dimethoxyphenyl)ethyl)-2-methylisoquinoline (S)-(+)-homolaudanosine (-)-Homolaudanosine (1R)-1-[2-(4-hydroxyphenyl)ethyl]-6-methoxy-2-methyl-3,4-dihydro-1H-isoquinolin-7-ol (1S)-1-[2-(4-hydroxy-3-methoxyphenyl)ethyl]-6-methoxy-2-methyl-1,2,3,4-tetrahydroisoquinolin-2-ium-7-ol (1S)-1-[2-(4-hydroxyphenyl)ethyl]-6-methoxy-2-methyl-1,2,3,4-tetrahydroisoquinolin-2-ium-7-ol (1R)-1-[2-(4-hydroxy-3-methoxyphenyl)ethyl]-6-methoxy-2-methyl-3,4-dihydro-1H-isoquinolin-7-ol (1S)-1-[2-(4-hydroxy-3-methoxyphenyl)ethyl]-6-methoxy-2-methyl-3,4-dihydro-1H-isoquinolin-7-ol (S)-1-[2-(4-Hydroxy-phenyl)-ethyl]-6-methoxy-2-methyl-1,2,3,4-tetrahydro-isoquinolin-7-ol (1R)-1-[2-(4-hydroxy-3-methoxyphenyl)ethyl]-6-methoxy-2-methyl-1,2,3,4-tetrahydroisoquinolin-2-ium-7-ol (1R)-1-[2-(4-hydroxyphenyl)ethyl]-6-methoxy-2-methyl-1,2,3,4-tetrahydroisoquinolin-2-ium-7-ol (1S)-1-[2-(4-hydroxy-3,5-dimethoxyphenyl)ethyl]-6-methoxy-2-methyl-3,4-dihydro-1H-isoquinolin-7-ol N-Methyl-1-(3,5-dimethoxy-4-hydroxy-phenethyl)-2-methyl-7-hydroxy-6-methoxy-1,2,3,4-tetrahydro-isochinolin (1R)-1-[2-(4-hydroxy-3,5-dimethoxyphenyl)ethyl]-6-methoxy-2-methyl-3,4-dihydro-1H-isoquinolin-7-ol (1S)-1-[2-[4-[[(1R)-1-[2-(4-hydroxyphenyl)ethyl]-6-methoxy-2-methyl-3,4-dihydro-1H-isoquinolin-7-yl]oxy]phenyl]ethyl]-6-methoxy-2-methyl-3,4-dihydro-1H-isoquinolin-7-ol 1-{2-[4-({1-[2-(4-Hydroxyphenyl)ethyl]-6-methoxy-2-methyl-1,2,3,4-tetrahydroisoquinolin-7-yl}oxy)phenyl]ethyl}-6-methoxy-2-methyl-1,2,3,4-tetrahydroisoquinolin-7-ol 1-[2-(4-hydroxyphenyl)ethyl]-7-methoxy-2-methyl-3,4-dihydro-1H-isoquinolin-6-ol 7-Hydroxy-1-(3-hydroxy-4,5-dimethoxy-phenethyl)-6-methoxy-2-methyl-1,2,3,4-tetrahydro-isochinolin 7-Hydroxy-1-(4-hydroxy-phenethyl)-6-methoxy-2-methyl-1,2,3,4-tetrahydro-isochinolin, 1-<2-(p-Hydroxy-phenyl)-ethyl>-2-methyl-6-methoxy-7-hydroxy-1,2,3,4-tetrahydro-isochinolin (+/-)-isoautumnaline homolaudanosine 7-methoxy-1-(4-methoxyphenylethyl)-2-methyl-1,2,3,4-tetrahydroisoquinolin-6-ol